Novo Nordisks oral Wegovy pill received a Commissioners National Priority Vouchera signature initiative of Commissioner Makary
PlexusDx serves all 50 states, accepts no insurance requirement, and qualifies for HSA/FSA, making prescription-strength therapy more accessible than traditional pharmacy channels
To cope, businesses are promoting products with more protein, tweaking labeling to say they are GLP-1 friendly, and working with large retailers to better market products
May 12, 2025: More Patients Sue Because of Side Effects of Ozempic and GLP-1 Products There are 1,809 lawsuits pending against the companies that made and sold Ozempic, the semaglutide medicine used to treat things like diabetes and obesity
Anti-Aging Properties: Diminish signs of aging for a youthful appearance